Neuros Medical, an Aliso Viejo, CA-based bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life, received $25M in Growth Capital.

Neuros Medical是一家位于加利福尼亚州Aliso Viejo的生物电力技术公司，致力于缓解慢性截肢后疼痛和恢复生活质量，获得2500万美元的增长资本。

The round was led by Trinity Capital (NASDAQ: TRIN).

该轮由三位一体首都（纳斯达克股票代码：TRIN）领导。

The company intends to use the funds to augment the recent equity raised and further scale operations to assist with their commercial launch.

该公司打算利用这些资金来增加最近筹集的股权和进一步扩大规模的运营，以协助其商业化推出。

Led by David Veino, President and CEO, Neuros Medical is a bioelectric technology company that has developed the Altius system for the treatment of chronic post-amputation pain (Phantom Limb Pain and Residual Limb Pain). The Altius System incorporates the company’s patented platform technology, On-Demand Bioelectric Nerve Block, which patients initiate as needed for targeted pain relief.

由Neuros Medical总裁兼首席执行官David Veino领导，该公司开发了Altius系统，用于治疗慢性截肢后疼痛（幻肢痛和残肢疼痛）。Altius系统结合了该公司专利的平台技术，即按需生物电神经阻滞，患者可根据需要启动针对性疼痛缓解。

The technology blocks sensory nerves and has the potential to alleviate pain in people with phantom limb and residual limb pain, fulfilling a significant need for patients. This system also has the potential to reduce drug dependency as existing treatment options are primarily limited to opioids and gabapentinoids.

该技术阻断感觉神经，并有可能减轻幻肢和残肢疼痛患者的疼痛，满足患者的重大需求。该系统还具有降低药物依赖性的潜力，因为现有的治疗选择主要限于阿片类药物和加巴喷丁类药物。

.

.

FinSMEs

金融中小企业

31/10/2023

31/10/2023